Neo-Penotran Forte 7 vaginal suppositories — Made in Turkey — Free Delivery

Brand: EXELTIS
Product Code: Neo-Penotran Forte
Availability: In Stock

$37.50

Description

Product description

Neo-penotran® Forte vaginal suppositories are used to treat candidal vulvovaginitis caused by Candida albicans, bacterial vaginosis caused by anaerobic bacteria and Gardnerella vaginalis, trichomonas vaginitis caused by Trichomonas vaginalis, and mixed vaginal infections.

Compound

1 suppository contains (active ingredients):

metronidazole - 750 mg;

miconazole nitrate - 200 mg.

The excipient is witepsol.

Contraindications

hypersensitivity to any of the active ingredients of the preparation or to their derivatives;
the use of alcoholic beverages during treatment or within 3 days after treatment;
taking disulfiram during treatment or within 2 weeks after treatment;
porphyria;
epilepsy;
severe liver dysfunction.

Mode of application

One vaginal suppository should be injected deep into the vagina at night for 7 days.

In case of recurrence of the disease or vaginitis resistant to other treatment, the preparation should be used within 14 days.

It is not recommended to use "Neo-penotran® Forte" during menstruation due to a decrease in the effectiveness of the preparation and the possibility of some complications when administered.

Application features

pregnant

Pregnancy - category C.

Since the effects of the active ingredients of the preparation on the fetus and the development of newborns are not fully understood, women who need to use this preparation should avoid pregnancy using an effective contraceptive method.

Data from preclinical animal studies on pregnancy, embryonic and fetal development, perinatal and/or postnatal development are insufficient. The possible risk to humans is unknown.

The preparation "Neo-penotran® Forte" should not be used in the first trimester of pregnancy. In the II and III trimesters, the preparation can be used only if necessary, if the doctor decides that the benefits outweigh the risks.

There is no evidence of a harmful effect on human and animal fertility when metronidazole or miconazole nitrate are used alone.

During the use of the preparation, breast-feeding should be stopped, since metronidazole, one of the active components of the preparation, passes into breast milk. Breastfeeding can be resumed 1-2 days after the end of treatment.

Children

The preparation is not recommended for children.

Drivers

Systemic use of metronidazole may affect the ability to drive or use machines. Compared with systemic administration, the absorption of metronidazole is significantly lower with vaginal administration. There is a possibility of dizziness, ataxia, psycho-emotional disorders. In the presence of such symptoms, it is not recommended to drive vehicles or other mechanisms.

Overdose

There are no data on an overdose of metronidazole when administered vaginally. When introduced into the vagina, metronidazole can be absorbed in an amount sufficient to cause systemic effects.

If a large amount of the preparation accidentally enters the digestive system, if necessary, an appropriate method of gastric lavage should be used. Treatment should be carried out in cases where 12 g of metronidazole has entered the digestive system. There is no specific antidote, symptomatic treatment is recommended. With an overdose of metronidazole, the following symptoms are observed: nausea, vomiting, abdominal pain, diarrhea, itching, metallic taste in the mouth, ataxia, vertigo, paresthesia, convulsions, leukopenia, dark urine.

With an overdose of miconazole nitrate, the following symptoms are observed: nausea, vomiting, inflammation of the throat and mouth, anorexia, headache, diarrhea.

Side effects

In some cases, side effects such as hypersensitivity reactions (including skin rashes) and abdominal pain, headache, itching, burning and irritation of the vagina can be observed. The incidence of systemic side effects is very low due to the very low level of metronidazole in blood plasma with vaginal use of the preparation (2-12% of the level achieved with oral metronidazole). Another active ingredient of the preparation, miconazole nitrate, can cause vaginal irritation (burning, itching), like all other antifungal agents containing imidazole derivatives that are administered vaginally (2-6%). If severe irritation occurs, treatment should be discontinued.

Storage conditions

Store at a temperature not exceeding 25 ° C, out of the reach of children. The preparation can be stored in the refrigerator at a temperature of 2-8°C. Do not freeze.

Shelf life - 3 years.

0 reviews

There are no reviews for this product.